Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBDJuly 11, 2022PsoriasisPsoriatic ArthritisMixed Topics
No more ‘escape hatch’: Post Roe, new worries about meds linked to birth defectsJune 29, 2022Psoriatic ArthritisPediatricsAutoimmune Diseases
Treat-to-target strategy with tapering proves effective in PsA and axSpAJune 27, 2022Psoriatic Arthritis
Serum brodalumab levels linked with treatment outcomes in patients with psoriasisJune 2, 2022PsoriasisPsoriatic Arthritis
Severe infections often accompany severe psoriasisMay 17, 2022PsoriasisPsoriatic ArthritisInfectious Diseases
Upadacitinib earns FDA approval for ankylosing spondylitis May 2, 2022Psoriatic ArthritisAtopic Dermatitis
Parents’ autoimmune diseases may affect children’s developmentMay 2, 2022PsoriasisPsoriatic Arthritis
Long-term efficacy, safety data for ixekizumab in pediatric psoriasis reportedApril 25, 2022PsoriasisPsoriatic ArthritisPediatrics
Secukinumab’s antipsoriatic effects confirmed in U.S. patient populationApril 25, 2022Psoriatic ArthritisPsoriasis
Hypocaloric diet controls joint activity in psoriatic arthritis – regardless of weight lossApril 14, 2022Psoriatic Arthritis
